Immune response and protection in mice inoculated with Leishmania amazonensis clones expressing different degrees of virulence

Parasitology Research

Volumn 83, Issue 7, 1997, Pages 690-697

  Soares Da Fonseca, André Luis ^a   Lima Vallochi, Adriana ^a   De Camargo Furtado, Glaucia ^a   De Almeida Abrahamsohn, Ises ^a   Collet De Araujo Lima, Glória M ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ARTICLE; CLONING; IMMUNE RESPONSE; LEISHMANIA; LEISHMANIASIS; MOUSE; NONHUMAN; PARASITE VIRULENCE; PRIORITY JOURNAL; T LYMPHOCYTE;

ANIMALS; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; HYPERSENSITIVITY, DELAYED; IMMUNIZATION; LEISHMANIA MEXICANA; LEISHMANIASIS, CUTANEOUS; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL;

ANIMALIA; LEISHMANIA AMAZONENSIS;

EID: 0030857006     PISSN: 00443255     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004360050321     Document Type: Article

References (34)

1. Abrams JS, Roncarolo MG, Yssel H, Andersson U, Gleich GJ, Silver JE (1992) Strategies of anti-cytokine monoclonal antibody development: immunoassay of IL-10 and IL-5 in clinical samples. Immunol Rev 127: 5-24
2. Aebischer T, Morris L, Handman E (1994) Intravenous injection of irradiated Leishmania major into susceptible BALB/c mice: immunization or protective tolerance. Int Immunol 6: 1535-1543
3. Andrade ZA, Reed SG, Roters SB, Sadigursky M (1984) Immunopathology of experimental cutaneous leishmaniasis. Am J Pathol 114: 137-148
4. Barral A, Petersen EA, Sacks DL, Neva FA (1983) Late metastatic leishmaniasis in the mouse: a model for mucocutaneous disease. Am J Trop Med Hyg 32: 277-285
5. Barral-Netto M, Reed SG, Sadigursky M, Sonnenfeld G (1987) Specific immunization of mice against Leishmania mexicana amazonensis using solubilized promastigotes. Clin Exp Immunol 67: 11-19
6. Bastien P, Blaineau C, Taminh M, Rioux JA, Roizes G, Pages M (1990) Interclonal variations in molecular karyotype in Leishmania infantum imply a "mosaic" strain structure. Mol Biochem Parasitol 40: 53-61
7. Behin R, Mauel J, Sordat B (1979) Leishmania tropica: pathogenicity and in vitro macrophage function in strains of inbred mice. Exp Parasitol 48: 81-91
8. Chaudhuri G, Chang K-P (1988) Acid protease activity of a major surface membrane glycoprotein (gp63) from Leishmania mexicana promastigotes. Mol Biochem Parasitol 27: 43-52
9. Cherwinski HM, Schumaker JH, Brown KD, Mossman TR (1987) Two types of mouse helper T cell clones. III. Further differences in lymphokine synthesis between TH1 and TH2 clones revealed by RNA hybridization, functionally monospecific assays and monoclonal antibodies. J Exp Med 166: 1229-1244
10. Convit J, Pinardi ME, Rondón AJ (1972) Diffuse cutaneous leishmaniasis: a disease due to an immunological defect of the host. Trans R Soc Trop Med Hyg 66: 603-610
11. Franke ED, McGreevy PB, Katz SP, Sacks DL (1985) Growth cycle-dependent generation of complement-resistant Leishmania promastigotes. J Immunol 134: 2713-2718
12. Gorczynski RM (1985) Immunization of susceptile BALB/c mice against Leishmania braziliensis. II. Use of temperature-sensitive avirulent clones of parasite for vaccination purposes. Cell Immunol 94: 11-20
13. Greenblatt CL, Handman E, Mitchell GF, Battye FL, Schnur LF, Snary D (1985) Phenotypic diversity of cloned lines of Leishmania major promastigotes. Z Parasitenkd 71: 141-157
14. Handman E, Ceredig R, Mitchell GF (1979) Murine cutaneous leishmaniasis: disease patterns in intact and nude mice of various genotypes and examination of some differences between normal and infected macrophages. Aust J Exp Biol Med Sci 57: 9-29.
15. Handman E, Hocking RE, Mitchell GF, Spithill TW (1983) Isolation and characterization of infective and non-infective clones of Leishmania tropica. Mol Biochem Parasitol 7: 111-126
16. Howard JG, Nicklin S, Hale C, Liew FY (1982) Prophylactic immunization against experimental leishmaniasis. I. Protection induced in mice genetically vulnerable to fatal Leishmania tropica infection. J Immunol 129: 2206-2212
17. + T cells which protect susceptible BALB/c mice against infection with virulent L. major. Infect Immun 61: 5205-5213
18. Kink JA, Chang K-P (1988) N-glycosylation as a biochemical basis for virulence in Leishmania mexicana amazonensis. Mol Biochem Parasitol 27: 181-190
19. Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685
20. Lainson R, Shaw JJ (1978) Epidemiology and ecology of leishmaniasis in Latin America. Nature 273: 595-600
21. Macatonia SE, Doherty TM, Knight SC, O'Garra A (1993) Differential effect of IL-10 on dendritic cell-induced T cell proliferation and IFN-γ production. J Immunol 150: 3755-3765
22. Marchand M, Daoud S, Titus RG, Louis J, Boon T (1987) Variants with reduced virulence derived from Leishmania major after mutagen treatment. Parasite Immunol 9: 81-92
23. McElrath MJ, Murray HW, Cohn ZA (1987) The local cellular immune response in experimental leishmaniasis. Ann Inst Pasteur Immunol 138: 787-790
24. McGurn M, Boon T, Louis JA, Titus RG (1990) Leishmania major: nature of immunity induced by immunization with a mutagenized avirulent clone of the parasite in mice. Exp Parasitol 71: 81-89
25. Mitchell GF, Handman E, Spithill TW (1984) Vaccination against cutaneous leishmaniasis in mice using nonpathogenic cloned promastigotes of Leishmania major and importance of route of injection. Aust J Exp Biol Med Sci 62: 145-153
26. Mitchell GF, Handman E, Spithill TW (1985) Examination of variables in the vaccination of mice against cutaneous leishmaniasis using living avirulent cloned lines and killed promastigotes of Leishmania major. Int J Parasitol 15: 677-684
27. Molyneux DH, Ashford RW (1983) The biology of Trypanosoma and Leishmania, parasites of man and domestic animals. Taylor and Francis, London, pp 228-249
28. Murray PJ, Handman E, Glaser TA, Spithill TW (1990) Leishmania major: expression and gene structure of the glycoprotein 63 molecule in virulent and avirulent clones and strains. Exp Parasitol 71: 294-304
29. Sacks DL, Perkins PV (1984) Identification of an infective stage of Leishmania promastigotes. Science 223: 1417-1419
30. Saraiva EMB, Andrade AFB, Pereira MEA (1986) Cell surface carbohydrate of Leishmania mexicana amazonensis: differences between infective and non-infective forms. Eur J Cell Biol 40: 219-225
31. Segovia M, Artero JM, Mellado E (1992) Effects of long-term in vitro cultivation on the virulence of cloned lines of Leishmania major promastigotes. Ann Trop Med Parasitol 86: 347-354
32. Titus RG, Marchand M, Boon T, Louis JA (1985) A limiting dilution assay for quantifying Leishmania major in tissues of infected mice. Parasite Immunol 7: 545-555
33. Titus RG, Gueiros-Filho FJ, De Freitas LAR, Beverley SM (1995) Development of a safe live Leishmania vaccine line by gene replacement. Proc Natl Acad Sci USA 92: 10267-10271
34. Towbin H, Stachelin T, Gordon J (1979) Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedures and some applications. Proc Natl Acad Sci USA 76: 4350-4354